Drug

(daunorubicin And Cytarabine) Liposome

63 flagged reaction(s) · 2,804 total co-reports · max PRR 168.6

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Acute Myeloid Leukaemia	287	168.6	192.0	signal
2	Febrile Neutropenia	502	68.6	87.1	signal
3	Cytopenia	80	60.5	62.6	signal
4	Bacteraemia	57	43.7	44.7	signal
5	Therapeutic Product Effect Incomplete	195	24.8	27.0	signal
6	Bone Marrow Failure	52	22.9	23.4	signal
7	Toxic Skin Eruption	23	20.5	20.7	signal
8	Device Related Infection	31	18.1	18.3	signal
9	Myelosuppression	66	17.4	17.9	signal
10	Drug Eruption	34	17.3	17.6	signal
11	Pneumocystis Jirovecii Pneumonia	19	17.1	17.2	signal
12	Mucosal Inflammation	47	16.2	16.5	signal
13	Septic Shock	75	15.6	16.1	signal
14	Ejection Fraction Decreased	24	13.9	14.0	signal
15	Disseminated Intravascular Coagulation	20	12.7	12.8	signal
16	Acute Respiratory Distress Syndrome	25	12.7	12.8	signal
17	Rash Maculo-papular	29	11.8	11.9	signal
18	Neutrophil Count Decreased	51	11.3	11.5	signal
19	Sepsis	134	10.8	11.4	signal
20	Cardiomyopathy	16	9.7	9.8	signal
21	Pericarditis	18	9.7	9.8	signal
22	Hepatocellular Injury	14	8.8	8.9	signal
23	Haemorrhoids	19	8.7	8.8	signal
24	Cellulitis	45	8.0	8.2	signal
25	Multiple Organ Dysfunction Syndrome	23	7.4	7.5	signal
26	Hepatic Cytolysis	10	7.4	7.4	signal
27	Cerebral Haemorrhage	29	7.3	7.4	signal
28	Cardiogenic Shock	11	6.9	7.0	signal
29	Bacterial Infection	14	6.8	6.8	signal
30	Clostridium Difficile Colitis	8	6.8	6.8	signal
31	Haemorrhage Intracranial	11	6.6	6.6	signal
32	Generalised Oedema	9	6.6	6.6	signal
33	Thrombotic Microangiopathy	7	6.5	6.5	signal
34	Fungal Infection	24	6.5	6.5	signal
35	Myelodysplastic Syndrome	10	6.2	6.2	signal
36	Acute Respiratory Failure	13	6.1	6.1	signal
37	Disease Progression	79	6.0	6.2	signal
38	Pancytopenia	37	6.0	6.0	signal
39	Posterior Reversible Encephalopathy Syndrome	6	5.7	5.7	signal
40	Myocarditis	7	5.6	5.6	signal
41	Neoplasm	7	5.5	5.5	signal
42	Arrhythmia	28	5.3	5.3	signal
43	Tooth Abscess	6	5.3	5.3	signal
44	Rectal Haemorrhage	24	5.0	5.0	signal
45	Platelet Count Decreased	58	4.9	5.0	signal
46	Cholestasis	10	4.7	4.7	signal
47	Pulmonary Oedema	23	4.6	4.6	signal
48	Colitis	19	4.5	4.6	signal
49	Epistaxis	37	4.4	4.5	signal
50	Neutropenia	66	4.4	4.5	signal
51	Thrombocytopenia	54	4.3	4.4	signal
52	Petechiae	5	4.3	4.3	signal
53	Haemoptysis	13	4.2	4.2	signal
54	Blood Lactate Dehydrogenase Increased	7	3.9	4.0	signal
55	Erythema Multiforme	4	3.9	3.9	signal
56	Folliculitis	4	3.5	3.5	signal
57	Product Administration Error	7	3.1	3.2	signal
58	Gastrointestinal Haemorrhage	28	3.0	3.0	signal
59	Death	228	2.4	2.5	signal
60	Uveitis	3	2.0	2.0	no signal
61	Drug Reaction With Eosinophilia And Systemic Symptoms	5	1.8	1.8	no signal
62	Palmar-plantar Erythrodysaesthesia Syndrome	4	1.5	1.5	no signal
63	Bladder Cancer	3	0.5	0.5	no signal